N/A
N=107
Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM)
Breast Cancer
Bottom Line
View on ClinicalTrials.gov: NCT00999596 ↗Enrolled (actual)
107
Serious AEs
0.0%
Results posted
May 2012
Primary outcome: Primary: FFDM (Full Field Digital Mammography) Mammogram Scores — 12; 0 FFDM Mammogram set
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- Female
- Sponsor
- Philips Healthcare
- Primary completion
- Jan 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY FFDM (Full Field Digital Mammography) Mammogram Scores |
12; 0 | — |
Summary
The purpose of this investigation, using hardcopy film, is to compare the accuracy of the Philips MammoDiagnost DR (FFDM device) and screen-film (SF) mammography in detection of breast cancer among women undergoing screening or diagnostic mammography.
Per the new FDA Guidance document for FFDM, accuracy in comparison to Screen-film is no longer required.
Eligibility Criteria
Inclusion Criteria
- Patient underwent or is scheduled to undergo a screening or diagnostic mammogram examination (right and left craniocaudal and mediolateral oblique with or without special views) at one of the acquisition centers during the course of this research study.
- At least 40 years of age
- Provides written informed consent indicating willingness to participate in this research study prior to performance of the Philips FFDM mammogram
- Meets none of the exclusion criteria
Exclusion Criteria
- Presence of a breast implant,
- Patients undergoing a unilateral mammogram or an incomplete SF mammogram
- had previously undergone an excisional breast biopsy
- Pregnant women or patients who believe they may be pregnant
(f) Inmates (in accordance with 45 CFR 46.306)
(g) Patients who cannot, for any reason, undergo follow-up mammography examinations (where clinically indicated) at the participating institution
Data sourced from ClinicalTrials.gov (NCT00999596). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.